These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 9055837)

  • 21. Dichotic listening tests of functional brain asymmetry predict response to fluoxetine in depressed women and men.
    Bruder GE; Stewart JW; McGrath PJ; Deliyannides D; Quitkin FM
    Neuropsychopharmacology; 2004 Sep; 29(9):1752-61. PubMed ID: 15238992
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Paroxetine treatment of anger associated with depression.
    Albritton J; Borison RL
    J Nerv Ment Dis; 1995 Oct; 183(10):666-7. PubMed ID: 7561816
    [No Abstract]   [Full Text] [Related]  

  • 23. Paroxetine in depressed adolescents with intellectual disability: an open label study.
    Masi G; Marcheschi M; Pfanner P
    J Intellect Disabil Res; 1997 Jun; 41 ( Pt 3)():268-72. PubMed ID: 9219077
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical application of paroxetine for tapering benzodiazepine use in non-major-depressive outpatients visiting an internal medicine clinic.
    Nakao M; Takeuchi T; Nomura K; Teramoto T; Yano E
    Psychiatry Clin Neurosci; 2006 Oct; 60(5):605-10. PubMed ID: 16958945
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A double-blind comparison of fluvoxamine and paroxetine in the treatment of depressed outpatients.
    Kiev A; Feiger A
    J Clin Psychiatry; 1997 Apr; 58(4):146-52. PubMed ID: 9164424
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Triiodothyronine potentiation of fluoxetine in depressed patients.
    Joffe RT
    Can J Psychiatry; 1992 Feb; 37(1):48-50. PubMed ID: 1551045
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effectiveness of fluoxetine and doxepin in treatment of melancholia in depressed patients.
    Sandor P; Baker B; Irvine J; Dorian P; McKessok D; Mendlowitz S
    Depress Anxiety; 1998; 7(2):69-72. PubMed ID: 9614594
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The efficacy of fluoxetine combined with a heterocyclic antidepressant in treatment-resistant depression: a retrospective analysis.
    Zajecka JM; Jeffries H; Fawcett J
    J Clin Psychiatry; 1995 Aug; 56(8):338-43. PubMed ID: 7635848
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Paroxetine prevents migraines.
    Hays P
    J Clin Psychiatry; 1997 Jan; 58(1):30-1. PubMed ID: 9055836
    [No Abstract]   [Full Text] [Related]  

  • 30. Clinical outcomes and genome-wide association for a brain methylation site in an antidepressant pharmacogenetics study in Mexican Americans.
    Wong ML; Dong C; Flores DL; Ehrhart-Bornstein M; Bornstein S; Arcos-Burgos M; Licinio J
    Am J Psychiatry; 2014 Dec; 171(12):1297-309. PubMed ID: 25220861
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of motivational pharmacotherapy on treatment retention among depressed Latinos.
    Lewis-Fernández R; Balán IC; Patel SR; Sánchez-Lacay JA; Alfonso C; Gorritz M; Blanco C; Schmidt A; Jiang H; Schneier F; Moyers TB
    Psychiatry; 2013; 76(3):210-22. PubMed ID: 23965261
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predictors of treatment utilization in major depression.
    Alonzo DM; Harkavy-Friedman JM; Stanley B; Burke A; Mann JJ; Oquendo MA
    Arch Suicide Res; 2011; 15(2):160-71. PubMed ID: 21541862
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ethnic differences in the risks of adverse reactions to drugs used in the treatment of psychoses and depression: a systematic review and meta-analysis.
    Ormerod S; McDowell SE; Coleman JJ; Ferner RE
    Drug Saf; 2008; 31(7):597-607. PubMed ID: 18558793
    [TBL] [Abstract][Full Text] [Related]  

  • 34. State of the science on psychosocial interventions for ethnic minorities.
    Miranda J; Bernal G; Lau A; Kohn L; Hwang WC; LaFromboise T
    Annu Rev Clin Psychol; 2005; 1():113-42. PubMed ID: 17716084
    [No Abstract]   [Full Text] [Related]  

  • 35. Discontinuation of antidepressant medication among Latinos in the USA.
    Hodgkin D; Volpe-Vartanian J; Alegría M
    J Behav Health Serv Res; 2007 Jul; 34(3):329-42. PubMed ID: 17570068
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An open-label study of SSRI treatment in depressed hispanic and non-Hispanic women.
    Alonso M; Val E; Rapaport MH
    J Clin Psychiatry; 1997 Jan; 58(1):31. PubMed ID: 9055837
    [No Abstract]   [Full Text] [Related]  

  • 37. Response to SSRI antidepressants correlates with reduction in plasma HVA: pilot study.
    Salzman C; Jimerson D; Vasile R; Watsky E; Gerber J
    Biol Psychiatry; 1993 Oct; 34(8):569-71. PubMed ID: 8274586
    [No Abstract]   [Full Text] [Related]  

  • 38. Paroxetine in the elderly depressed patient: randomized comparison with fluoxetine of efficacy, cognitive and behavioural effects.
    Geretsegger C; Böhmer F; Ludwig M
    Int Clin Psychopharmacol; 1994; 9(1):25-9. PubMed ID: 8195578
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fluoxetine-induced akathisia does not reappear after switch to paroxetine.
    Bauer M; Hellweg R; Baumgartner A
    J Clin Psychiatry; 1996 Dec; 57(12):593-4. PubMed ID: 9010125
    [No Abstract]   [Full Text] [Related]  

  • 40. [Paroxetine in the treatment of depression in geriatric patients--a double-blind comparative study with fluoxetine].
    Schöne W; Ludwig M
    Fortschr Neurol Psychiatr; 1994 Sep; 62 Suppl 1():16-8. PubMed ID: 7959520
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.